Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.5324
-0.01
(-1.12%)
USD |
OTCM |
Sep 09, 16:00
Reviva Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 15.21M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.21M |
| March 31, 2026 | 17.44M |
| December 31, 2025 | 8.648M |
| September 30, 2025 | 4.550M |
| June 30, 2025 | -0.4591M |
| March 31, 2025 | -4.46M |
| December 31, 2024 | 0.8126M |
| September 30, 2024 | -9.982M |
| June 30, 2024 | -6.042M |
| March 31, 2024 | -1.346M |
| December 31, 2023 | 5.719M |
| September 30, 2023 | -8.519M |
| June 30, 2023 | 1.621M |
| March 31, 2023 | 5.785M |
| December 31, 2022 | 12.32M |
| September 30, 2022 | 20.36M |
| June 30, 2022 | 16.06M |
| Date | Value |
|---|---|
| March 31, 2022 | 21.36M |
| December 31, 2021 | 28.69M |
| September 30, 2021 | 32.27M |
| June 30, 2021 | 34.52M |
| March 31, 2021 | 4.516M |
| February 28, 2021 | |
| November 30, 2020 | |
| August 31, 2020 | |
| May 31, 2020 | |
| February 29, 2020 | 57.76M |
| November 30, 2019 | 64.16M |
| August 31, 2019 | 64.02M |
| May 31, 2019 | 63.75M |
| February 28, 2019 | 63.41M |
| November 30, 2018 | 63.10M |
| August 31, 2018 | 62.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Jaguar Health, Inc. | 6.615M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.14M |
| Total Liabilities (Quarterly) | 5.933M |
| Debt to Equity Ratio | 0.0095 |
| Current Ratio | 3.563 |
| Net Debt Paydown Yield | 0.19% |